Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: Recommendations

Scandinavian Journal of Work, Environment and Health

Volumn 41, Issue 1, 2015, Pages 5-15

  Wolff, Henrik ^a   Vehmas, Tapio ^a   Oksa, Panu ^a   Rantanen, Jorma ^b   Vainio, Harri ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b International Commission on Occupational Health (ICOH)   (Finland)

Author keywords

Asbestos; Asbestosis; Cancer; Consensus report; Exposure assessment; Helsinki criteria

Indexed keywords

ASBESTOS; BIOLOGICAL MARKER;

ASBESTOS; CANCER; OCCUPATIONAL EXPOSURE; POLLUTION EXPOSURE; PUBLIC HEALTH;

ARTICLE; ASBESTOSIS; CANCER DIAGNOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; FINLAND; FOLLOW UP; HUMAN; IMMUNIZATION; LUNG CANCER; MALIGNANT MESOTHELIOMA; MEDICAL DOCUMENTATION; NEOPLASM; OVARY CANCER; PLEURA THICKENING; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS; STOMACH CANCER; BLOOD; CONSENSUS DEVELOPMENT; FEMALE; MALE; MESOTHELIOMA; NEOPLASMS; OCCUPATIONAL EXPOSURE; PLEURAL DISEASES; PRACTICE GUIDELINE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STANDARDS;

FINLAND; HELSINKI; VARSINAIS-SUOMI;

ASBESTOS; ASBESTOSIS; BIOLOGICAL MARKERS; FEMALE; FINLAND; GUIDELINES AS TOPIC; HUMANS; MALE; MESOTHELIOMA; NEOPLASMS; OCCUPATIONAL EXPOSURE; PLEURAL DISEASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROPERITONEAL FIBROSIS;

EID: 84921906914     PISSN: 03553140     EISSN: 1795990X     Source Type: Journal    
DOI: 10.5271/sjweh.3462     Document Type: Article

References (26)

1. World Health Organization (WHO). Asbestos: elimination of asbestos-related diseases. Fact sheet no. 343. Paris:WHO; 2010. Available from: http://www.who.int/mediacentre/ factsheets/fs343/en/index.html.
2. Tossavainen A, Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health. 1997;23(4):311-6. http://dx.doi.org/10.5271/ sjweh.226
3. Tossavainen A. International expert meeting on new advances in the radiology and screening of asbestos-related diseases. Scand J Work Environ Health. 2000;26(5):449-54. http:// dx.doi.org/10.5271/sjweh.567
4. Asbestos Asbestosis and Cancer, the Helsinki Criteria for Diagnosis and Attribution 2014. Helsinki: Finnish Institute of Occupational Health; 2014. Available from: www.ttl.fi/ hcuasbestos.
5. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409. http://dx.doi.org/10.1056/NEJMoa1102873
6. American Lung Association. Providing guidance on lung cancer screening to patients and physicians. Washington DC: American Lung Association; 2012. Available from: http:// www.lung.org/lung-disease/lung-cancer/lung-cancerscreening- guidelines/lung-cancer-screening.pdf.
7. Wender R, Fontham ET, Barrera E, Jr., Colditz GA, Church TR, Ettinger DS, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63(2):107-17. http://dx.doi.org/10.3322/caac.21172
8. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e78S- 92S.
9. Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330-8http://dx.doi.org/10.7326/M13-
10. Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S,. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012;144(1):33-8. http://dx.doi.org/10.1016/j.jtcvs.2012.05.060
11. Wood DE, Eapen GA, Ettinger DS, Hou L, Jackman D, Kazerooni E, et al. Lung cancer screening. J Natl Compr Canc Netw. 2012;10(2):240-65.
12. Kjuus H, Vehmas T, Finkelstein M, Kraus T, Kishimoto T, Frilander H, et al. Follow-up of asbestos exposed workers and diagnosis of non-malignant asbestos diseases. Helsinki: Finnish Institute of Occupational Health; 2014. Available from: www.ttl.fi/hcuasbestos.
13. International Labor Organization (ILO). Guidelines for the use of the ILO international classification of radiographs of pneumoconioses. Geneva: ILO; Revised edition 1980/2000
14. Kusaka Y, Hering KG, Parker JE. International Classification of HRCT for occupational and enviromental diseases. Tokyo: Springer; 2005.
15. Suganuma N, Kusaka Y, Hering KG, Vehmas T, Kraus T, Arakawa H, et al. Reliability of the proposed international classification of high-resolution computed tomography for occupational and environmental respiratory diseases. J Occup Health. 2009;51(3):210-22. http://dx.doi.org/10.1539/joh. L8030
16. Roggli VL, Gibbs AR, Attanoos R, Churg A, Popper H, Cagle P, et al. Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of American pathologists and pulmonary pathology society. Arch Pathol Lab Med. 2010;134(3):462-80.
17. Weissman D, Gustavsson P, Miller A, Rushton L, Stayner L, Pallasaho P, et al. New Asbestos Related Disease Entities. Helsinki: Finnish institute of Occupational Health; 2014. Available from: www.ttl.fi/hcuasbestos.
18. A review of human Carcinogens. Arsenic, Metals, Fibres and Dust. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. 100 part C. Lyon: IARC; 2012.
19. Travis W, Colby TV, Corrin B, Shimosato Y, Brambilla E. The World Health Organization Histological Typing of Lung and Pleural Tumours. 3 rd ed. Berlin: Springer Verlag; 1999.
20. Roggli VL, Anttila S, Kane A, Inai K, Wolff H. Pathology and Biomarkers. Helsinki: Finnish Institute of Occupational Health; 2014. Available from: www.ttl.fi/hcuasbestos.
21. Blanquart C, Gueugnon F, Nguyen JM, Roulois D, Cellerin L, Sagan C, et al. CCL2, galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusions. J Thorac Oncol. 2012;7(5):883-9. http://dx.doi.org/10.1097/ JTO.0b013e31824c9272
22. Savic S, Franco N, Grilli B, Barascud Ade V, Herzog M, Bode B, et al. Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology. Chest. 2010;138(1):137-44.
23. Han J, Cao S, Zhang K, Zhao G, Xin Y, Dong Q, et al. Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions. J Cardiothorac Surg. 2012;7:121. http://dx.doi.org/10.1186/1749-8090-7-121
24. Nymark P, Aavikko M, Makila J, Ruosaari S, Hienonen- Kempas T, Wikman H, et al. Accumulation of genomic alterations in 2p16, 9q33.1 and 19p13 in lung tumours of asbestos-exposed patients. Mol Oncol. 2013;7(1):29-40. http:// dx.doi.org/10.1016/j.molonc.2012.07.006
25. Vehmas T, Sauni R, Miller AB, Straif K, Malila N, Smith RA. Screening for asbestos-related lung cancer. Helsinki Finnish Institute of Occupational Health; 2014. Available from: www. ttl.fi/hcuasbestos
26. The Helsinki Declaration on Management and Elimination of Asbestos-Related Diseases. Available from: http://www. icohweb.org/site_new/ico_news_detail.asp?id=86.